Back to NMRA
MARSHALL WACE, LLP NMRA Position History
Neumora Therapeutics, Inc. • Healthcare
Quarters held
9
Latest value
$1.1M
Q2 2026
Peak value
$3.4M
First seen
Q3 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2023 | $3.4M |
| Q3 2023 | $194K |
| Q2 2024 | $1.3M |
| Q2 2025 | $51K |
| Q2 2025 | $131K |
| Q4 2025 | $106K |
| Q4 2025 | $939K |
| Q2 2026 | $403K |
| Q2 2026 | $1.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.1M | 667.2K | — | — |
| Q2 2026 | $403K | 237.2K | — | — |
| Q4 2025 | $939K | 524.6K | — | — |
| Q4 2025 | $106K | 59.2K | — | — |
| Q2 2025 | $131K | 180.0K | — | — |
| Q2 2025 | $51K | 70.5K | — | — |
| Q2 2024 | $1.3M | 134.5K | — | — |
| Q3 2023 | $194K | 13.8K | — | — |
| Q3 2023 | $3.4M | 242.6K | — | — |